E.E. Geduld’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

E.E. Geduld’s Portfolio IMNP Stock Details IMNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5K	Hold	1,250	–	–	﹤0.01%	169
2016 Q3	$7K	Hold	1,250	–	–	0.01%	178
2016 Q2	$10K	Hold	1,250	–	–	0.01%	154
2016 Q1	$11K	Sell	1,250 -500	-29%	-$5.13K	0.02%	143
2015 Q4	$26K	Hold	1,750	–	–	0.02%	154
2015 Q3	$41K	Hold	1,750	–	–	0.04%	158
2015 Q2	$68K	Hold	1,750	–	–	0.04%	226
2015 Q1	$63K	Hold	1,750	–	–	0.04%	213
2014 Q4	$66K	Sell	1,750 -250	-13%	-$13.4K	0.04%	195
2014 Q3	$134K	Buy	+2,000	New	+$142K	0.09%	165

Other funds holding IMNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

E.E. Geduld's IMNP Position: Q4 2016 in Review

E.E. Geduld held its Immune Pharmaceuticals Inc. (IMNP) position steady in Q4 2016 at 1,250 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #169.

E.E. Geduld first reported a position in IMNP in Q3 2014 and has held it in 10 quarters since. The position peaked at $134K in Q3 2014. 14 funds tracked by Wall St. Rank hold IMNP as of Q4 2016.

E.E. Geduld held 1,250 shares of Immune Pharmaceuticals Inc. worth $5K as of Q4 2016.
E.E. Geduld left its Immune Pharmaceuticals Inc. share count unchanged in Q4 2016.
Immune Pharmaceuticals Inc. made up ﹤0.01% of E.E. Geduld's portfolio in Q4 2016, its #169 holding.
E.E. Geduld first reported a position in Immune Pharmaceuticals Inc. in Q3 2014 and has held it in 10 quarters since.
E.E. Geduld's Immune Pharmaceuticals Inc. position peaked at $134K in Q3 2014.
14 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.